.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.. advertisement
.
lawmakers should revisit that idea when lepage is no longer in office next year..
�such figures underline how vital it is that the government supports the nhs to improve waiting times this year.�.
ben - ?????